AI-generated summary
The authors tested defocused high-power laser protocols on the C2C12 myoblast cell line in vitro, comparing them with low-power laser therapy. They report that cell viability was not changed by the treatments, while all protocols accelerated scratch closure and cell migration, with the 2 W dual-wavelength protocol showing the most pronounced effect. As a laboratory study on cultured cells, the findings do not directly establish effects in people.
- Who or what was studied
- C2C12 myoblast cell line (in vitro cultured cells)
- Wavelengths
- 810, 980 nm
- Limits stated in the abstract
- The study was conducted only on a cultured cell line in vitro, so results may not translate to living tissue or patients.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on link.springer.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Power
- 0.1 W, 1 W, 2 W
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Laser, Photobiomodulation therapy, Wavelength, Sham, Photobiomodulation. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.